share_log

424B2: Prospectus

SEC ·  Aug 19 06:05

Summary by Moomoo AI

JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the offering of Structured Investments Review Notes linked to the MerQube US Tech+ Vol Advantage Index, with a maturity date of September 2, 2027. These notes, guaranteed by JPMorgan Chase & Co., are designed for investors seeking the potential for early exit at a premium if the Index reaches or exceeds the Call Value on any Review Date, starting from February 28, 2025. The notes carry risks, including the loss of principal if the Index falls below a certain level, and are subject to a 6.0% per annum daily deduction and a notional financing cost, which may negatively impact the Index's performance. The notes are unsecured and unsubordinated obligations of...Show More
JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the offering of Structured Investments Review Notes linked to the MerQube US Tech+ Vol Advantage Index, with a maturity date of September 2, 2027. These notes, guaranteed by JPMorgan Chase & Co., are designed for investors seeking the potential for early exit at a premium if the Index reaches or exceeds the Call Value on any Review Date, starting from February 28, 2025. The notes carry risks, including the loss of principal if the Index falls below a certain level, and are subject to a 6.0% per annum daily deduction and a notional financing cost, which may negatively impact the Index's performance. The notes are unsecured and unsubordinated obligations of JPMorgan Financial, with payments fully guaranteed by JPMorgan Chase & Co. The offering, with notes priced at $1,000 each and minimum denominations of $1,000, is expected to price on or about August 28, 2024, and settle on or about August 30, 2024. The notes are not bank deposits, are not FDIC insured, and involve a number of risks detailed in the accompanying prospectus supplements and underlying supplement. The SEC has not approved or disapproved of the notes nor passed upon the accuracy or adequacy of the pricing supplement or the accompanying documents.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more